Heartflow HTFL

What to see in Heartflow now

Is Wall Street adding or cutting?+24

193 13F filers hold it · +24 against the quarter before · shares held +15.0%

Holdings of 06/30

Is stock about to come to market?$8.1M

$8.1M of planned sales filed in 30 days · 0.2% of the units outstanding

Filed 09/18

Who bought more than 5%?9.8%

BCLS Fund III Investments holds 9.8% · −2.4pp on the report before

Filed 08/14

$8.1M of planned sales filed in 30 days · 0.2% of the units outstandingFiled 09/18

	Trade type
John C.M. FarquharChief Executive Officer	Open-market sale10b5-1 plan	06/24	06/26	38,900 sh	$35.00	$1,361,500	−7.8%
John C.M. FarquharChief Executive Officer	Open-market sale10b5-1 plan	06/10	06/12	22,562 sh	$28.50	$643,017	−4.3%
Campbell RogersChief Medical Officer	Open-market sale10b5-1 plan	05/18	05/20	9,219 sh	$28.34	$261,266.46	−10.5%
John C.M. FarquharChief Executive Officer	Open-market sale10b5-1 plan	05/11	05/13	22,562 sh	$29.12	$657,005.44	−4.2%
Bain Capital Life Sciences III General Partner10% Owner	Open-market sale	04/30	04/30	892,533 sh	$29.18	$26,044,112.94	−9.5%


Vikram VergheseOfficer	HeartflowHTFL10b5-1 plan	16,766 sh	$850,926.94	09/18	Filed 09/18
Campbell RogersMember of immediate family of any of the foregoing	HeartflowHTFL10b5-1 plan	5,653 sh	$283,497.95	09/18	Filed 09/18
Campbell RogersOfficer	HeartflowHTFL10b5-1 plan	19,682 sh	$987,052.3	09/18	Filed 09/18
Vikram VergheseOfficer	HeartflowHTFL10b5-1 plan	7,579 sh	$379,815.26	09/17	Filed 09/17
Vikram VergheseOfficer	HeartflowHTFL10b5-1 plan	668 sh	$33,408	09/15	Filed 09/15
Vikram VergheseOfficer	HeartflowHTFL10b5-1 plan	4,593 sh	$230,743.5	09/14	Filed 09/14
John C.M. FarquharOfficer, Director	HeartflowHTFL10b5-1 plan	3,890 sh	$194,500	09/11	Filed 09/11
Vikram VergheseOfficer	HeartflowHTFL10b5-1 plan	29,714 sh	$1,487,459.84	09/11	Filed 09/11
John C.M. FarquharOfficer, Director	HeartflowHTFL10b5-1 plan	35,010 sh	$1,625,104.29	09/10	Filed 09/10
Vikram VergheseOfficer	HeartflowHTFL10b5-1 plan	6,640 sh	$332,211.7	09/08	Filed 09/08